Celgene announced that Bob Hugin will retire as executive chairman on February 5 – a signal that he is about to enter the race for U.S. Senator. He will also give up his seat on the Board of Directors of the pharmaceutical giant.
“It has been a tremendous privilege to be part of Celgene’s growth and to help advance Celgene’s mission to serve patients through scientific breakthroughs in the treatment of cancer and other serious medical conditions,” Hugin said. “I am thankful to my colleagues at Celgene, as well as to patient advocates, medical researchers and physicians across New Jersey and throughout the healthcare system for their collaboration in advancing this fundamentally important mission in the service of patients.”